{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:41:44Z","timestamp":1780461704493,"version":"3.54.1"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.5843","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T22:10:33Z","timestamp":1468534233000},"page":"1919-1922","source":"Crossref","is-referenced-by-count":5,"title":["Brain Metabolic Changes of Cervical Dystonia with Spinocerebellar Ataxia Type 1 after Botulinum Toxin Therapy"],"prefix":"10.2169","volume":"55","author":[{"given":"Akio","family":"Kikuchi","sequence":"first","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"},{"name":"Department of Neurology, National Hospital Organization Sendai-Nishitaga Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Sugeno","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Konno","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Oshima","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Watanuki","sequence":"additional","affiliation":[{"name":"Division of Cyclotron Nuclear Medicine, Cyclotron and Radioisotope Centre, Tohoku University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Hiraoka","sequence":"additional","affiliation":[{"name":"Division of Cyclotron Nuclear Medicine, Cyclotron and Radioisotope Centre, Tohoku University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Tashiro","sequence":"additional","affiliation":[{"name":"Division of Cyclotron Nuclear Medicine, Cyclotron and Radioisotope Centre, Tohoku University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Giladi N. The mechanism of action of botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site. J Neurol Sci 152: 132-135, 1997.","DOI":"10.1016\/S0022-510X(97)00151-2"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kanovsky P, Streitova H, Dufek J, Znojil V, Daniel P, Rektor I. Change in lateralization of the P22\/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A. Mov Disord 13: 108-117, 1998.","DOI":"10.1002\/mds.870130122"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ceballos-Baumann AO, Sheean G, Passingham RE, Marsden CD, Brooks DJ. Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp. A PET study. Brain 120 (Pt 4): 571-582, 1997.","DOI":"10.1093\/brain\/120.4.571"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Etgen T, Muhlau M, Gaser C, Sander D. Bilateral grey-matter increase in the putamen in primary blepharospasm. J Neurol Neurosurg Psychiatry 77: 1017-1020, 2006.","DOI":"10.1136\/jnnp.2005.087148"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Onodera Y, Aoki M, Tsuda T, et al. High prevalence of spinocerebellar ataxia type 1 (SCA1) in an isolated region of Japan. J Neurol Sci 178: 153-158, 2000.","DOI":"10.1016\/S0022-510X(00)00390-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lee WY, Jin DK, Oh MR, et al. Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients. Arch Neurol 60: 858-863, 2003.","DOI":"10.1001\/archneur.60.6.858"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Pareyson D, Gellera C, Castellotti B, et al. Clinical and molecular studies of 73 Italian families with autosomal dominant cerebellar ataxia type I: SCA1 and SCA2 are the most common genotypes. J Neurol 246: 389-393, 1999.","DOI":"10.1007\/s004150050369"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sasaki H, Fukazawa T, Yanagihara T, et al. Clinical features and natural history of spinocerebellar ataxia type 1. Acta Neurol Scand 93: 64-71, 1996.","DOI":"10.1111\/j.1600-0404.1996.tb00173.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Wu YR, Lee-Chen GJ, Lang AE, Chen CM, Lin HY, Chen ST. Dystonia as a presenting sign of spinocerebellar ataxia type 1. Mov Disord 19: 586-587, 2004.","DOI":"10.1002\/mds.10708"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Genis D, Matilla T, Volpini V, et al. Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred: (CAG)n expansion and early premonitory signs and symptoms. Neurology 45: 24-30, 1995.","DOI":"10.1212\/WNL.45.1.24"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Magyar-Lehmann S, Antonini A, Roelcke U, et al. Cerebral glucose metabolism in patients with spasmodic torticollis. Mov Disord 12: 704-708, 1997.","DOI":"10.1002\/mds.870120513"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Galardi G, Perani D, Grassi F, et al. Basal ganglia and thalamo-cortical hypermetabolism in patients with spasmodic torticollis. Acta Neurol Scand 94: 172-176, 1996.","DOI":"10.1111\/j.1600-0404.1996.tb07049.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Giladi N, Meer J, Kidan H, Honigman S. Long-term remission of idiopathic cervical dystonia after treatment with botulinum toxin. Eur Neurol 44: 144-146, 2000.","DOI":"10.1159\/000008223"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Antonucci F, Rossi C, Gianfranceschi L, Rossetto O, Caleo M. Long-distance retrograde effects of botulinum neurotoxin A. J Neurosci 28: 3689-3696, 2008.","DOI":"10.1523\/JNEUROSCI.0375-08.2008"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Caleo M, Antonucci F, Restani L, Mazzocchio R. A reappraisal of the central effects of botulinum neurotoxin type A: by what mechanism? J Neurochem 109: 15-24, 2009.","DOI":"10.1111\/j.1471-4159.2009.05887.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/14\/55_55.5843\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T18:26:46Z","timestamp":1498328806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/14\/55_55.5843\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":15,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.5843","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}